AQR Capital Management
GRTS

AQR Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

AQR Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-129,996
Closed -$536K – 2323
2022
Q1 		$536K Buy
129,996
+24,128
+23% +$128K ﹤0.01% 1795
2021
Q4 		$1.36M Buy
105,868
+86,861
+457% +$962K ﹤0.01% 1398
2021
Q3 		$205K Sell
19,007
-21,736
-53% -$198K ﹤0.01% 2149
2021
Q2 		$372K Buy
+40,743
New +$377K ﹤0.01% 1987

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AQR Capital Management's GRTS Position: Q2 2022 in Review

AQR Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 129,996 shares — an estimated $536K sold.

AQR Capital Management first reported a position in GRTS in Q2 2021 and held it in 4 quarters. The position peaked at $1.36M in Q4 2021. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • AQR Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • AQR Capital Management sold 129,996 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $536K.
  • AQR Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • AQR Capital Management's Gritstone bio, Inc. Common Stock position peaked at $1.36M in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.